Lista de obras - Kasra Yousefi - Dominio Público Uruguay

A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.

artículo científico publicado en 2014

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

artículo científico publicado en 2017

Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer

artículo científico publicado en 2017

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes

artículo científico publicado en 2015

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy

artículo científico publicado en 2016

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence.

artículo científico publicado en 2014

Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.

artículo científico publicado en 2017

Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.

artículo científico publicado en 2016

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study

artículo científico publicado en 2017

Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality

artículo científico publicado en 2017

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis

artículo científico publicado en 2016

Gene Expression Correlates of Site-specific Metastasis Among Men With Lymph Node Positive Prostate Cancer Treated With Radical Prostatectomy: A Case Series

artículo científico publicado en 2017

Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model.

artículo científico publicado en 2017

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy

artículo científico publicado en 2015

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy

artículo científico publicado en 2014

Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists

artículo científico publicado en 2015

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease

artículo científico publicado en 2017

Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study

artículo científico

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients

artículo científico publicado en 2017

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

artículo científico publicado en 2016

Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer

artículo científico publicado en 2015

Pan-Cancer Analysis of Genomic Sequencing Among the Elderly

artículo científico publicado en 2017

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy

artículo científico publicado en 2017

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.

artículo científico publicado en 2016

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

artículo científico publicado en 2015

Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes

artículo científico publicado en 2017

Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men.

artículo científico publicado en 2015

Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy

artículo científico publicado en 2016

Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting

artículo científico publicado en 2015

Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features

artículo científico publicado en 2017

Lista de obras de Kasra Yousefi

A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence.

Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.

Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study

Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis

Gene Expression Correlates of Site-specific Metastasis Among Men With Lymph Node Positive Prostate Cancer Treated With Radical Prostatectomy: A Case Series

Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model.

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy

Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease

Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer

Pan-Cancer Analysis of Genomic Sequencing Among the Elderly

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes

Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men.

Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy

Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting

Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features